Trial Profile
A study of PREOB for the treatment of osteonecrosis
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 27 Dec 2022
Price :
$35
*
At a glance
- Drugs Autologous osteoblastic cell therapy Bone Therapeutics (Primary)
- Indications Osteonecrosis
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2017 New trial record